New topics in vasopressin receptors and approach to novel drugs: Effects of vasopressin receptor on regulations of hormone secretion and metabolisms of glucose, fat, and protein

Journal of Pharmacological Sciences

Volumn 109, Issue 1, 2009, Pages 50-52

  Tanoue, Akito ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Adrenocorticotropic hormone (ACTH); Arginine vasopressin; Hormone; Metabolism

Indexed keywords

ALDOSTERONE; ARGIPRESSIN; CORTICOTROPIN; FATTY ACID; GLUCAGON; INSULIN; VASOPRESSIN RECEPTOR; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V1B RECEPTOR;

ALDOSTERONE RELEASE; BODY FLUID; CORTICOTROPIN RELEASE; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HORMONAL REGULATION; HORMONE RELEASE; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPID METABOLISM; METABOLIC REGULATION; NONHUMAN; PROTEIN METABOLISM; SHORT SURVEY;

EID: 58649113015     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08R15FM     Document Type: Short Survey

References (14)

1. Michell RH, Kirk CJ, Billah MM. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans. 1979;7:861-865.
2. Antoni FA, Holmes MC, Makara GB, Karteszi M, Laszlo FA. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor. Peptides. 1984;5:519-522.
3. Tanoue A, Ito S, Oshikawa S, Kitagawa Y, Koshimizu T, Mori T, et al. The Vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest. 2004;113:302-309.
4. Lang RE, Heil JW, Ganten D, Hermann K, Unger T, Rascher W. Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology. 1983;37:314-316.
5. Nakamura K, Fujiwara Y, Mizutani R, Sanbe A, Miyauchi N, Hiroyama M, et al. Effects of vasopressin V1b receptor deficiency on ACTH release from anterior pituitary cells in response to oxytocin stimulation. Endocrinology. 2008;149: 4883-4891.
6. 1A receptor. Eur J Pharmacol. 2007;566:226-230.
7. Abu-Basha EA, Yibchok-anun S, Hsu WH. Glucose dependency of arginine vasopressin-induced insulin and glucagon release from the perfused rat pancreas. Metabolism. 2002;51:1184-1190.
8. Fujiwara Y, Hiroyama M, Sanbe A, Yamauchi J, Tsujimoto G, Tanoue A. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice. J Endocrinol. 2007;192:361-369.
9. Oshikawa S, Tanoue A, Koshimizu T, Kitagawa Y, Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: A combined pharmacological /knockout approach. Mol Pharmacol. 2004;65:623-629.
10. Zerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes. 1979;28:503-508.
11. Aoyagi T, Birumachi J, Hiroyama M, Fujiwara Y, Sanbe A, Yamauchi J, et al. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology. 2007;148: 2075-2084.
12. Fujiwara Y, Hiroyama H, Sanbe A, Aoyagi T, Birumachi J, Tsujimoto G, et al. Insulin hypersensitivity in mice lacking the V1b vasopressin receptor. J Physiol. 2007;584:235-244.
13. Hiroyama M, Aoyagi T, Fujiwara Y, Birumachi J, Shigematsu Y, Kiwaki K, et al. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol Endocrinol. 2007;21:247-258.
14. Hiroyama H, Aoyagi T, Fujiwara Y, Oshikawa S, Sanbe A, Endo F, et al. Hyperammonemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume. J Physiol. 2007;581:1183-1192.